With health debate resolved, investors see continued health sector growth

NewsGuard 100/100 Score

After months of uncertainty during the health-overhaul debate, financial analysts and mutual fund managers are feeling more stable and seeing upsides from the new law, The New York Times reports. "There does not seem to be any onerous cost control," one analyst said. Another added, "There is just an expansion of coverage [and] not a lot of surprises."

"Over all, fund managers tend to be bullish on most health-related sectors with the exception of the health insurance industry, where it's harder to gauge the impact of new regulations" (Fabrikant, 4/9).

Investment News: "Health care stocks have long been regarded by investors as conservative, defensive positions," because of their "necessary and desirable products," an aging population and resilience to economic slumps. None of that's changed. "The result of these domestic trends is that [CMS, the agency that runs Medicare] expects health care spending to grow 6.2% through 2018, nearly three times faster than the overall 2.1% growth of the U.S. economy" (Schoenstein, 4/11). 

Meanwhile, the Des Moines Register reports that "President Barack Obama has promoted annuities as an effective tool for retirement savings. But a little-noticed tax in the health care reconciliation bill imposes a 3.8 percent tax on annuities purchased by high-income earners. ... The tax is the unearned income Medicare contribution. It taxes nonqualified annuity payouts, interest and rental income, dividends and capital gains of couples earning more than $250,000 [annually], or singles with more than $200,000" (Mracek, 4/11).


Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Biden is right about $35 insulin cap but exaggerates prior costs for Medicare enrollees